Neurociencias
Departamento
University Hospital of Bern
Berna, SuizaPublicaciones en colaboración con investigadoras/es de University Hospital of Bern (3)
2020
-
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial
The Lancet Neurology, Vol. 19, Núm. 3, pp. 226-233
-
Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
Genetics in Medicine, Vol. 22, Núm. 9, pp. 1478-1488
-
The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis
Cells, Vol. 9, Núm. 1